What is Cockayne Syndrome

Cockayne syndrome is a rare, progressive genetic disorder characterized by impaired growth, neurological dysfunction, and extreme sensitivity to sunlight. It is caused by defects in the body’s ability to repair damaged DNA, leading to multisystem degeneration and a significantly shortened lifespan.

What causes Cockayne syndrome?

Cockayne syndrome is an autosomal recessive disorder, meaning an individual must inherit two faulty copies of specific genes—most commonly ERCC6 (CSB) or ERCC8 (CSA)—to manifest the condition. These genes are essential for transcription-coupled nucleotide excision repair, a process that fixes DNA damage caused by UV light or metabolic byproducts. When this mechanism fails, cells accumulate damage, leading to the premature cellular aging and cell death characteristic of Cockayne syndrome.

How is Cockayne syndrome classified?

Clinicians typically categorize Cockayne syndrome into three main types based on the severity and age of symptom onset:

• Type I (Classic): Symptoms appear in early childhood; life expectancy is typically into the second decade.


• Type II (Severe/Cerebro-Oculo-Facio-Skeletal syndrome): Symptoms are present at or shortly after birth, with very limited physical and neurological development.


• Type III (Mild): Late-onset, slower progression, and often a longer life expectancy compared to other types.

How common is Cockayne syndrome?

Cockayne syndrome is extremely rare, with an estimated prevalence of approximately 1 in 200,000 births in the United States and Europe. It affects males and females equally, with no known ethnic or geographic predilection. Because the condition is so rare, our community at DiseaseMaps.org currently counts 2 members living with this diagnosis, highlighting the importance of specialized global support networks.

What differentiates Cockayne syndrome from other progeroid syndromes?

While Cockayne syndrome involves "premature aging," it is distinct from conditions like Hutchinson-Gilford progeria. Unlike other progeroid syndromes, Cockayne syndrome does not typically present with the classic signs of accelerated aging like hair loss or cardiovascular disease. Instead, it is uniquely defined by severe neurological impairment, microcephaly, and extreme photosensitivity without an increased risk of skin cancer.

Next steps

• Consult a clinical geneticist for formal diagnostic testing and genetic counseling.


• Work with a multidisciplinary team including neurologists, ophthalmologists, and physical therapists to manage symptoms.


• Connect with the Cockayne syndrome community at DiseaseMaps.org to share experiences and find resources.


• Review clinical trial information via NIH GARD or patient-led foundations to stay updated on emerging research.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Cockayne Syndrome


• Orphanet: Rare Disease Database (ORPHA:187)


• OMIM (Online Mendelian Inheritance in Man): Entry #216400


• Cockayne Syndrome Support Group (UK/International)